JP2017500295A5 - - Google Patents

Download PDF

Info

Publication number
JP2017500295A5
JP2017500295A5 JP2016533648A JP2016533648A JP2017500295A5 JP 2017500295 A5 JP2017500295 A5 JP 2017500295A5 JP 2016533648 A JP2016533648 A JP 2016533648A JP 2016533648 A JP2016533648 A JP 2016533648A JP 2017500295 A5 JP2017500295 A5 JP 2017500295A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
pharmaceutically acceptable
acceptable salt
tautomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016533648A
Other languages
English (en)
Japanese (ja)
Other versions
JP6838966B2 (ja
JP2017500295A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/066965 external-priority patent/WO2015077655A1/en
Publication of JP2017500295A publication Critical patent/JP2017500295A/ja
Publication of JP2017500295A5 publication Critical patent/JP2017500295A5/ja
Application granted granted Critical
Publication of JP6838966B2 publication Critical patent/JP6838966B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016533648A 2013-11-22 2014-11-21 デスフェリチオシン類似体およびその使用 Expired - Fee Related JP6838966B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361907913P 2013-11-22 2013-11-22
US61/907,913 2013-11-22
PCT/US2014/066965 WO2015077655A1 (en) 2013-11-22 2014-11-21 Desferrithiocin analogs and uses thereof

Publications (3)

Publication Number Publication Date
JP2017500295A JP2017500295A (ja) 2017-01-05
JP2017500295A5 true JP2017500295A5 (enExample) 2018-08-16
JP6838966B2 JP6838966B2 (ja) 2021-03-03

Family

ID=53180232

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533648A Expired - Fee Related JP6838966B2 (ja) 2013-11-22 2014-11-21 デスフェリチオシン類似体およびその使用

Country Status (6)

Country Link
US (1) US10010535B2 (enExample)
EP (1) EP3071201A4 (enExample)
JP (1) JP6838966B2 (enExample)
AU (1) AU2014352780A1 (enExample)
CA (1) CA2930966A1 (enExample)
WO (1) WO2015077655A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2614086T3 (es) 2005-04-04 2017-05-29 University Of Florida Research Foundation, Inc. Análogos de poliéter de desferritiocina
WO2013090750A1 (en) 2011-12-16 2013-06-20 University Of Florida Research Foundation, Inc. Uses of 4'-desferrithiocin analogs
CA2984250A1 (en) 2015-04-27 2016-11-03 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof
EA039916B1 (ru) * 2015-10-23 2022-03-28 Вифор (Интернациональ) Аг Новые ингибиторы ферропортина
JP6810988B2 (ja) * 2015-10-23 2021-01-13 ヴィフォール （インターナショナル） アクチェンゲゼルシャフトＶｉｆｏｒ （Ｉｎｔｅｒｎａｔｉｏｎａｌ） ＡＧ 新規なフェロポーチン阻害剤
US10982136B2 (en) 2016-02-26 2021-04-20 The Regents Of The University Of California Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters
ES3015117T3 (en) 2016-08-29 2025-04-29 Fred Hutchinson Cancer Center Chelating platform for delivery of radionuclides
DK3509595T3 (da) * 2016-09-06 2023-01-23 Univ California Formuleringer af hydroxypyridonat-actinid/lanthanid-dekorporeringsmidler
EP3520117B1 (en) 2016-09-29 2023-11-08 The Regents of The University of California Separation of metal ions by liquid-liquid extraction
CA3038670A1 (en) 2016-09-29 2018-04-05 The Regents Of The University Of California Chelating molecules
JOP20180036A1 (ar) 2017-04-18 2019-01-30 Vifor Int Ag أملاح لمثبطات فروبورتين جديدة
TW202102478A (zh) 2019-04-01 2021-01-16 瑞士商威佛（國際）股份有限公司 新穎的鐵螯合物
JP7554253B2 (ja) * 2019-07-19 2024-09-19 ヴィフォール （インターナショナル） アクチェンゲゼルシャフト 輸血依存性β－サラセミア（ＴＤＴ）の治療で使用するためのフェロポーチン阻害剤

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274207A (en) 1966-09-20 Processes for preparing thiazole carboxylic acids
US3809754A (en) 1968-12-31 1974-05-07 Medial De Toledo & Cie Method of treating diseases of the mucous membrane using compounds of a thiazolidine carboxylic acid and pharmaceutical preparations thereof
US3882110A (en) 1969-06-11 1975-05-06 Roussel Uclaf Novel 2-alkyl-5-thiazole-carboxylic acid derivatives
DE2045818A1 (de) 1969-09-17 1971-04-08 Godo Shusei Kabushiki Kaisha, Tokio Aeruginoinsäure und Verfahren zu ihrer Herstellung
FR2141526B1 (enExample) 1971-06-14 1975-05-30 Roussel Uclaf
DE2245560A1 (de) 1972-09-16 1974-03-21 Basf Ag Verfahren zur herstellung von 4alkoxycarbonyl-2-thiazolinen
AU528115B2 (en) 1978-04-08 1983-04-14 Santen Pharmaceutical Co. Ltd. Antihypertensive 4-thiazolidine/carboxylic acids
DE3002989A1 (de) 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
EP0045281B1 (de) 1980-07-28 1985-05-08 Ciba-Geigy Ag Thiazolinderivate und Verfahren zu ihrer Herstellung
JPS5758682A (en) 1980-07-28 1982-04-08 Ciba Geigy Ag Thiazoline derivatives, manufacture and medicinal composition containing same
JPS5772975A (en) 1980-10-24 1982-05-07 Kureha Chem Ind Co Ltd 2-substituted phenylthiazole derviative, and medicine for peptic ulcer containing said derivative as active component
US4367233A (en) 1981-10-02 1983-01-04 American Home Products Corporation Inhibitors of mammalian collagenase
HU200177B (en) 1985-06-18 1990-04-28 Biogal Gyogyszergyar Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
EP0214933A3 (de) 1985-09-03 1989-05-24 Ciba-Geigy Ag Kombinationspräparate zur Behandlung von Malaria
EP0214101A3 (de) 1985-09-03 1989-05-31 Ciba-Geigy Ag Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria
JPS62142168A (ja) 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
DE3621540A1 (de) 1986-06-27 1988-01-07 Basf Ag Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von bakterien und pilzen
DE3735757A1 (de) 1987-10-22 1989-05-03 Degussa Optisch aktive salze aus einem substituierten thiazolidin-4-carboxylat und 3-chlor-2-hydroxypropyltrimethylammonium, deren herstellung und verwendung
ES2047149T3 (es) 1988-01-20 1994-02-16 Ciba Geigy Ag Procedimiento para la obtencion de compuestos complejos.
GB8826035D0 (en) 1988-11-07 1988-12-14 Ici Plc Herbicidal compositions
US5182402A (en) 1988-11-07 1993-01-26 Imperial Chemical Industries Plc Herbicidal compositions
US5106992A (en) 1989-07-28 1992-04-21 E. R. Squibb & Sons, Inc. 3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
NL9001955A (nl) 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
US5393777A (en) 1990-11-15 1995-02-28 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Deferration using anguibactin siderophore
DE69132944T2 (de) 1990-11-30 2002-11-21 Otsuka Pharmaceutical Co., Ltd. Azolederivate als Inhibitor von Superoxide-Radikalen
DE122008000051I1 (de) 1990-11-30 2009-02-05 Teijin Ltd 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
FR2677021B1 (fr) 1991-05-31 1993-10-01 Upsa Laboratoires Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
WO1994011367A1 (en) 1992-11-16 1994-05-26 University Of Florida Research Foundation Inc. 2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives
US5840739A (en) 1992-11-16 1998-11-24 University Of Florida Research Foundation, Inc. Thiazoline acid derivatives
DE4301356A1 (de) 1993-01-20 1994-07-21 Basf Ag Verfahren zur Herstellung von 2-Alkyl-4-fluormethyl-thiazolcarbonsäure-alkylestern
FR2749583B1 (fr) 1996-06-07 1998-08-21 Lipha Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
US20020049316A1 (en) 1997-04-29 2002-04-25 Halbert Stacie Marie Protease inhibitors
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
US6147070A (en) 1998-06-05 2000-11-14 Facchini; Francesco Methods and compositions for controlling iron stores to treat and cure disease states
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US6159983A (en) 1998-09-18 2000-12-12 University Of Florida Method and composition for treatment of inflammatory bowel disease
CN1585639A (zh) * 1998-09-21 2005-02-23 佛罗里达大学研究基金会 抗疟疾制剂
US6251927B1 (en) 1999-04-20 2001-06-26 Medinox, Inc. Methods for treatment of sickle cell anemia
DE19948434A1 (de) 1999-10-08 2001-06-07 Gruenenthal Gmbh Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
US7160855B2 (en) 2002-03-14 2007-01-09 Children's Hospital & Research Center At Oakland Enhancement of iron chelation therapy
WO2004017959A2 (en) 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
AU2004270261B2 (en) 2003-09-09 2008-12-04 University Of Florida Research Foundation, Inc. Polyamine-metal chelator conjugates
WO2005034949A1 (en) 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
CA2587558A1 (en) 2004-11-19 2006-05-26 Shiva Biomedical, Llc Methods of treating erythropoietin-resistance
ES2614086T3 (es) 2005-04-04 2017-05-29 University Of Florida Research Foundation, Inc. Análogos de poliéter de desferritiocina
US20080194518A1 (en) 2005-12-23 2008-08-14 MOOKERJEE Pradip Antimicrobial Compositions
CN101129381B (zh) 2006-08-25 2012-02-01 天津和美生物技术有限公司 含β-内酰胺类抗生素和离子螯合剂的抗生素复方
WO2008130395A2 (en) 2006-12-12 2008-10-30 University Of Florida Desferrithiocin analogue actinide decorporation agents
NZ579994A (en) 2007-03-15 2011-09-30 Univ Florida Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal
FR2922210A1 (fr) 2007-10-11 2009-04-17 Univ Louis Pasteur Etablisseme Nouveaux composes, preparation et utilisations
CA2728636A1 (en) * 2008-07-14 2010-01-21 Ferrokin Biosciences, Inc. Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
JP2013500342A (ja) * 2009-07-27 2013-01-07 フェロキン バイオサイエンシーズ，インク． 金属キレート化剤としてのデサザデスフェロチオシンポリエーテルアナログのプロドラッグ
JP5925679B2 (ja) * 2009-08-25 2016-05-25 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド デスフェリチオシンポリエーテル類似体およびその使用
NZ603774A (en) * 2010-05-04 2014-11-28 Ferrokin Biosciences Inc Desazadesferrothiocin analogues as metal chelation agents
WO2012027794A2 (en) 2010-09-01 2012-03-08 The Mental Health Research Institute Of Victoria Method of treatment and agents useful for same
TW201338777A (zh) * 2011-12-09 2013-10-01 Ferrokin Biosciences Inc 用於治療金屬過載之經口調配物
WO2013090750A1 (en) * 2011-12-16 2013-06-20 University Of Florida Research Foundation, Inc. Uses of 4'-desferrithiocin analogs
WO2013090766A1 (en) * 2011-12-16 2013-06-20 University Of Florida Research Foundation, Inc. Uses of 3'-desferrithiocin analogs
WO2014134701A1 (en) 2013-03-07 2014-09-12 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2017500295A5 (enExample)
CA2791738C (en) Aryl imidazolyl compounds for the treatment of cancer
JP2017502006A5 (enExample)
CA3105748A1 (en) Pyridazine compounds for inhibiting nav1.8
RU2019129727A (ru) Применения пиримидопиримидинонов в качестве ингибиторов sik
JP2019094345A5 (enExample)
JP2017504595A5 (enExample)
JP2019504890A5 (enExample)
JP2015531773A5 (enExample)
JP2021152063A5 (enExample)
JP2018522866A5 (enExample)
JP2018515495A5 (enExample)
CA3002945A1 (en) Methods of using c-met modulators
JP2016074674A5 (enExample)
JP2013525495A (ja) 金属キレート化剤としてのデスアザデスフェリチオシン類似体
JP2021046404A5 (enExample)
HRP20211782T1 (hr) Derivati indola kao inhibitori replikacije denga virusa
JP2019535723A5 (enExample)
JP2013500342A (ja) 金属キレート化剤としてのデサザデスフェロチオシンポリエーテルアナログのプロドラッグ
JP2020516616A5 (enExample)
JP2023100842A (ja) 置換フェニルスルホニルフェニルトリアゾールチオンおよびその使用法
JP2018515475A5 (enExample)
JP2007503432A5 (enExample)
JP2019526593A5 (enExample)
TWI537280B (zh) 抗組蛋白去乙醯酶及３－羥－３－甲基戊二輔酶ａ還原酶之雙重作用抑制劑